Page 4 - Brainsway Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS to Treat Parkinson s Disease

BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS to Treat Parkinson s Disease
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

Israel generalColleen hanlonClinical affairs at brainswayBrainsway ltdClinical dataMultiple trials showed improvementsBoth motorDeep transcranial magnetic stimulationHuman neuroscienceClinical affairs

Brainsway Announces Positive Results In Late-Life Depression Post-Marketing Analysis

Brainsway Announces Positive Results In Late-Life Depression Post-Marketing Analysis
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Israel generalIdo maromChris boyerColleen hanlonBrian ritchieExchange commissionBrainsway ltdClinical affairs at brainsway weData publishedLeading peer reviewed publicationDeep transcranial magnetic stimulationToo lateLate life depressionClinical medicineVice presidentClinical affairs

BrainsWay : Report of Periodic or Interim Report -March 28, 2024 at 07:07 pm EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F .

United statesIsrael generalState of israelNexstim yingchiIdo maromHar hahotzvimInternational accounting standards boardSecurities exchangeCompany contact person securitiesUs veterans affairsInternational financial reporting standardsBrainsway ltdIsrael innovation authorityBynet buildingCompany contact personDepositary shares

Neurostar cleared for use in adolescent depression

The U.S. FDA granted Neuronetics Inc. clearance for use of its Neurostar advanced therapy as an adjunctive treatment of major depressive disorder in patients aged 15 to 21, making it the first transcranial magnetic stimulation treatment (TMS) cleared for this age group, the company said.

Neuronetics incBioworld medtechNeuronetics incBrainsway ltdMagstim co ltdMagnus medical incNexstim oyTranscranial magnetic stimulation tmsNeurology psychiatricMedical devices

BrainsWay Q4 Earnings Preview (NASDAQ:BWAY)

BrainsWay Q4 Earnings Preview (NASDAQ:BWAY)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Johns hopkinsBrainsway ltdFiring neuronsSeeking alphaMarket sizeGrandview researchGlobal expansionSmoking cessationRevenue trend